In 285 Bangladesh NSCLC patients, carriers of XPC rs2228001 AC or CC genotypes showed significant suffering from grade 3-4 neutropenia (OR = 2.63; 95% CI: 1.41–4.90; p = 0.002), while those harboring CC genotypes are less likely to develop grade 3-4 anemia, compared with AA genotype carriers (OR = 0.18; 95% CI: 0.04–0.82; p = 0.027) (Bushra et al., 2020). This evidence concerns the gene XPC and neutropenia.